3Mumby M.PP2A:unveiling a reluctant tumor suppressor[J].Cell,2007,130(1):21-24.
4Van Hoof C,Goris J.Phosphatases in apoptosis:to be or not to be,PP2Ais in the heart of the question[J].Biochim Biophys Acta,2003,1640(2-3):97-104.
5Gehringer MM.Microcystin-LR and okadaic acid-induced cellular effects:a dualistic response[J].FEBS Lett,2004,557(1-3):1-8.
6Saddoughi SA,Gencer S,Peterson YK,et al.Sphingosine analogue drug FTY720targets 12PP2A/ET and mediates lung tumour suppressionn via activation of PP2A-RIPKl-dependent necroptosis[J].EMBO Mol Med,2013,(5):105-121.
7Kong M,Ditsworth D,Lindsten T,et al.Alpha4is an essential regulator of PP2Aphosphatase activity[J].Mol Cell,2009,36(1):51-60.
8Zhivotovsky B,Kroemer G.Apoptosis and genomic instability[J].Nature Reviews Molecular Cell Biology,2004,5:752-762.
9Whelligan DK,Solanki S,Taylor D,et al.Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2:SAR and structural characterization[J].Journal of medicinal chemistry,2010,53:7682-7698.
10Hayward DG,Fry AM.Nek2kinase in chromosome instability and cancer[J].Cancer letters,2006,237:155-166.
